Literature DB >> 15651787

New synthesis of chiral 1,3-oxazinan-2-ones from carbohydrate derivatives.

Jean-Rene Ella-Menye1, Vibha Sharma, Guijun Wang.   

Abstract

Chiral 1,3-oxazinan-2-ones are useful intermediates in synthesizing pharmaceutical compounds and amino alcohols. In this paper, we report a new synthetic method to chiral 6-hydroxymethyl 1,3-oxazinan-2-ones and their analogues from carbohydrate derivatives. The synthesis was accomplished by the reaction of optically pure 3-hydroxy-gamma-butyrolactone with a primary amine to give an amide, which was reduced and carbonylated to give the desired compound class.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15651787     DOI: 10.1021/jo040224q

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Development of chiral fluorinated alkyl derivatives of emixustat as drug candidates for the treatment of retinal degenerative diseases.

Authors:  Eliav Blum; Jianye Zhang; Edward Korshin; Krzysztof Palczewski; Arie Gruzman
Journal:  Bioorg Med Chem Lett       Date:  2020-07-18       Impact factor: 2.823

2.  Imposing the trans/gauche conformation on a sialic acid donor with a 5-N,7-O-oxazinanone group: effect on glycosylation stereoselectivity.

Authors:  David Crich; Baolin Wu
Journal:  Tetrahedron       Date:  2008-02-25       Impact factor: 2.457

3.  Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy.

Authors:  Eliav Blum; Jianye Zhang; Jordan Zaluski; David E Einstein; Edward E Korshin; Adam Kubas; Arie Gruzman; Gregory P Tochtrop; Philip D Kiser; Krzysztof Palczewski
Journal:  J Med Chem       Date:  2021-06-03       Impact factor: 8.039

4.  Scaffolding-Induced Property Modulation of Chemical Space.

Authors:  Jingyao Li; Vincenzo Di Lorenzo; Pravin Patil; Angel J Ruiz-Moreno; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Marco A Velasco-Velázquez; Alexander Dömling
Journal:  ACS Comb Sci       Date:  2020-06-08       Impact factor: 3.784

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.